OncoSec Medical Inc (ONCSQ)

[guti]

Titan, thanks for the information. Like you said, Punit mentioned the melanoma combo may not see a licensing deal until 2018 (contingent on data of course) but I think the course has changed with the fast track acceptance that is mentioned on page 40. It will help to establish a partner that can help with further costs, since it is expected to be with a much larger population, by cutting valuable time that's needed to achieve FDA approval.